Skip to main content

Risk for Depressive Symptoms Increased for Perimenopausal Women

Medically reviewed by Carmen Pope, BPharm. Last updated on May 9, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 9, 2024 -- Perimenopausal women have an increased risk for depressive symptoms and diagnoses, according to a review published in the July 15 issue of the Journal of Affective Disorders.

Yasmeen Badawy, from University College London, and colleagues conducted a systematic review and meta-analysis to estimate the risk for developing clinical depression and depressive symptoms at different stages of menopause. Data from 17 prospective cohort studies with 16,061 women were included in the review. The meta-analyses included seven studies with 9,141 participants.

The researchers found that compared with premenopausal women, perimenopausal women had a significantly higher risk for depressive symptoms and diagnoses (odds ratio, 1.40). No significantly increased risk for depressive symptoms or diagnoses was seen for postmenopausal versus premenopausal women.

"Our study further solidifies the existing evidence on the association between the perimenopausal stage and the risk for depressive symptoms, including a significantly larger number and more diverse studies than in previous meta-analyses," the authors write. "Our findings highlight the need for early screening and treatment for depression in midlife women and further research into potential risk factors."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Parental Legal System Involvement Linked to Adverse Child Mental Health

THURSDAY, May 23, 2024 -- Parental legal system involvement may negatively impact child mental health, according to a study published online May 23 in Pediatrics. Lilian G...

Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot Flashes

MONDAY, May 20, 2024 -- Fezolinetant is safe and effective for moderate-to-severe vasomotor symptoms (VMS), according to a study presented at the annual European Congress of...

U-Shaped Link Detected Between Adolescent BMI and Mental Health

FRIDAY, May 17, 2024 -- There is a U-shaped association between adolescent body mass index (BMI) and mental health, according to a study published online May 15 in JAMA...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.